
Precision capital.
The brain is the asset.
A new category of private capital architecture.
Direct investments · Direct IP ownership · Zero management fees
Explore the FirmWe own the technology that measures it.
We back companies where that measurement changes what they're worth.
Where we invest: industries and companies where deploying neuroscience to improve how people think, decide and perform leads to enhanced performance — alpha generated by improving the cognitive capabilities of the organisation.
of venture financings return less than the capital invested.
And 65% of high-potential startups fail because of their people, not their product.
The technology rarely fails. The decisions do.
We are the firm that measures, prices and fixes them.
A neuroscience-powered
approach to capital.
We are an investment firm. We invest in companies, deploy our proprietary neuro-infrastructure inside them, improve how their people perform under pressure — and build the outperformance from the inside.
We call this the Cognitive Core: a decade of peer-reviewed neuroscience, authored at the source — and exceptionally hard to replicate.
A neuroscience method,
working as an investment tool.
The behavioural wind tunnel is pure neuroscience: it measures how people actually decide under real pressure, with clinical-grade accuracy. We run our investments through it — testing a company's people before capital goes in, and re-testing as the Cognitive Core improves them. Aviation stopped guessing when the wind tunnel arrived. So did we.
Method co-authored by our Chief Neuroscientist — Journal of Neuroscience, November 2025.
Inside the firmEvery exit returns more than just capital.
It builds the asset you own.
You invest once, at the parent. When a portfolio company exits, that capital comes back to you. The neuro-IP built inside the company stays — it flows back to the parent you own, making the next deployment cheaper, faster and better priced. One investment, two engines of return.
Positions rotate. The Core accumulates. That is the compounding.
Live investments. One compounding platform.
Cogwear
Clinical-grade EEG — brain data, measured anytime, anywhere. Deployed with NYU Langone, Penn, the NSF and MLB-affiliated programs.
cogweartech.com
FightIQ × WBC MUAY THAI
Our neuro-infrastructure deployed at global scale. 116 countries, 40,000+ sanctioned fighters. Launched Bangkok, June 2026.
fightiq.fitTwelve industries under evaluation — among them Mining Health & Safety · Boardroom Cognitive Risk · Elite Sports Performance
Launched with the WBC Muay Thai.
Our neuro-infrastructure IP goes global.
"Muay Thai is stepping into a new role — a sports industry creating economic value across tourism, technology, data and content." Andrew Murray · Thai Post · 24 June 2026Read the news
Where institutional capital meets authored neuroscience.

Peter Maher
Chairman · Institutional Governance
Former Macquarie Bank Group Executive Director and Group Head of Banking & Financial Services. Brings tier-one institutional governance discipline to the Cognition Alpha platform.

Andrew Murray
CEO · Strategic + Capital Architecture
Managing Director, Terranexx (next-generation agronomic and environmental platform). Managing Director, International Products Group. Former executive roles at Macquarie Bank and Westpac.

Dr Michael L. Platt
Chief Neuroscientist · Wharton
James S. Riepe Professor, University of Pennsylvania (PIK #16). Founding Director, Wharton Neuroscience Initiative. Former Director, Duke Institute for Brain Sciences. Over 27,000 academic citations.

Simon Butler
Advisor · Growth-Company Cognitive Deployment
Executive Chairman & CEO, eOne Solutions (enterprise software). Executive Chairman, Contivio.com (cloud contact-centre). Chairman & CEO, Red Rock Minerals. Serial chairman across software, communications and resources.

Gen. Thanapol Bhakdibhumi
Advisor · Thailand Wind Tunnel + WBC
Managing Director, GreenCal Thailand. President, WBC Muay Thai. President, WBC Asia Pacific. Anchors the Thailand calibration environment and the sports-performance vertical.

David Yonce
Advisor · CEO Cogwear
Chief Executive Officer, Cogwear — advancing clinical-grade EEG. Former VP Global Head of Innovation (CINO/CTO) at DSM Biomedical, transforming its medical-device portfolio. Advisory roles across neuro and orthopaedic ventures.
Institutional anchors UPenn / Wharton Neuroscience · Chulalongkorn University · Thailand BOI
Six people. One thesis. Built by the people who can deploy it.
Meet the team
Governed to institutional standard.
Structured, governed and administered by tier-one international firms — operating across Singapore, Bangkok, Philadelphia and Sydney.
Investors own the parent directly. 0% management fee · 0% carry — no fee leakage.
ContactThis website is provided for general information only. It does not constitute an offer of securities, an offering memorandum, or financial product advice, and may contain forward-looking statements that involve assumptions and uncertainties.